P

PT UBC Medical Indonesia Tbk
IDX:LABS

Watchlist Manager
PT UBC Medical Indonesia Tbk
IDX:LABS
Watchlist
Price: 139 IDR -0.71% Market Closed
Market Cap: 549.1B IDR

Net Margin
PT UBC Medical Indonesia Tbk

5.3%
Current
4%
Average
1.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.3%
=
Net Income
9.3B
/
Revenue
176.6B

Net Margin Across Competitors

No Stocks Found

PT UBC Medical Indonesia Tbk
Glance View

Market Cap
549.1B IDR
Industry
Health Care

PT UBC Medical Indonesia Tbk is a ID-based company operating in Health Care Providers & Services industry. The company is headquartered in Jakarta Timur, Dki Jakarta and currently employs 64 full-time employees. The company went IPO on 2024-07-10. PT UBC Medical Indonesia Tbk is an Indonesia-based medical diagnostic company. The firm provides affordable medical diagnostic tests and instruments for the Indonesian healthcare market. The firm operates through two segments: Medical disposable and consumables, and Diagnostic and equipment. The company offers various products to detect and diagnose various diseases, such as tuberculosis, cervical cancer, newborn screening, COVID-19, health risk screening with artificial intelligence (AI) and molecular systems. Its products include NeoMoDX Molecular System, Airdoc, QIAstat-DX Analyzer, Care HPV System, Hybrid Capture 2 - HPV DNA Test, Revvity SARS-COV-2 RT PCR, Geneproof SARS-COV-2 PCR KIT, Quantiferon TB Gold Plus, Genoscholar, Ina TB, GSP Neonatal Kit, Delfia Neonatal Kit, Neonatal Sampling Paper and Victor2 D.

LABS Intrinsic Value
75.37 IDR
Overvaluation 46%
Intrinsic Value
Price
P
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.3%
=
Net Income
9.3B
/
Revenue
176.6B
What is the Net Margin of PT UBC Medical Indonesia Tbk?

Based on PT UBC Medical Indonesia Tbk's most recent financial statements, the company has Net Margin of 5.3%.

Back to Top